Literature DB >> 23937747

Uniextrapedicular kyphoplasty for the treatment of thoracic osteoporotic vertebral fractures.

Zhaohui Ge, Rong Ma, Zhen Chen, Huiyong Zhang, Huiqiang Ding, Siming Liang, Zhigang Suo.   

Abstract

Osteoporotic vertebral compression fractures are common and cause pain and disability. Most osteoporotic vertebral compression fractures occur in the lower thoracic and thoracolumbar spine. Percutaneous balloon kyphoplasty through a transpedicular approach is a classic procedure performed to treat osteoporotic vertebral compression fractures. However, due to the slender morphology of the pedicles, small pedicle size, and the angular severity of thoracic kyphosis, performing kyphoplasty in middle and high thoracic levels is technically challenging. The purpose of this retrospective study was to evaluate the clinical outcomes of single-balloon kyphoplasty for the treatment of thoracic osteoporotic vertebral compression fractures via an extrapedicular approach. Between July 2004 and May 2008, thirty-eight patients with thoracic osteoporotic vertebral compression fractures underwent percutaneous kyphoplasty via a unilateral extrapedicular approach. Average patient age was 60.3 years. Symptomatic levels ranged from T4 to T12. All affected vertebrae were identified via physical examination, magnetic resonance imaging, and radiographs. Pain relief, vertebral height restoration, and kyphosis correction were compared pre- and postoperatively using the visual analog scale and radiographs. The operation was successful in all patients. Average injected bone cement volume was 3.2±1.4 mL. Mean follow-up was 9.5 months. Visual analog scale pain score improved in 36 of 38 patients postoperatively. Mean visual analog scale pain score was 8.92±0.682 preoperatively and 2.40±0.31 postoperatively and remained at 2.80±0.34 until last follow-up. Mean middle body height correction ratio was 50.9%±34.6%. No lateral wedging was found in the coronal alignment of the treated vertebrae. Three (7.9%) patients sustained cement extravasation with no adverse events. Kyphoplasty through a unilateral extrapedicular approach can achieve convergent and proper cement filling in the affected vertebrae to effectively restore stiffness, relieve pain, and correct kyphosis in fractured vertebrae. Copyright 2013, SLACK Incorporated.

Entities:  

Mesh:

Year:  2013        PMID: 23937747     DOI: 10.3928/01477447-20130724-17

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  5 in total

Review 1.  Is unilateral kyphoplasty as effective and safe as bilateral kyphoplasties for osteoporotic vertebral compression fractures? A meta-analysis.

Authors:  Zhaobo Huang; Shuanglin Wan; Lei Ning; Shiliang Han
Journal:  Clin Orthop Relat Res       Date:  2014-06-26       Impact factor: 4.176

2.  A study on the puncture method of extrapedicular infiltration anesthesia applied during lumbar percutaneous vertebroplasty or percutaneous kyphoplasty.

Authors:  Liehua Liu; Haoming Wang; Jiangang Wang; Qian Wang; Yu Pu; Zili Wang; Yuexiang Wu; Yuan Xu; Weidong Jin
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  Unilateral percutaneous vertebroplasty for osteoporotic lumbar compression fractures: a comparative study between transverse process root-pedicle approach and conventional transpedicular approach.

Authors:  Wenwu Zhang; Shenpeng Liu; Xianhua Liu; Xiang Li; Le Wang; Yong Wan
Journal:  J Orthop Surg Res       Date:  2021-01-21       Impact factor: 2.359

4.  Safety of Balloon Kyphoplasty in the Treatment of Thoracic Osteoporotic Vertebral Compression Fractures in Vietnamese Patients.

Authors:  Dinh-Hoa Nguyen; Duc-Dat Vu; Thi-Ngoc-Ha Doan; Hoang-Long Vo
Journal:  Clin Orthop Surg       Date:  2020-05-14

5.  Unilateral percutaneous kyphoplasty for lumbar spine: A comparative study between transverse process-pedicle approach and conventional transpedicular approach.

Authors:  Hongwei Wang; Pan Hu; Weijie Xu; Ying Feng; Yan Zhang; Yunpeng Zhu; Weijian Ren; Liangbi Xiang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.